| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |